CYTK

Cytokinetics, Incorporated

Contracts

Total Value

Stock Metrics

12.4%

Short % Float

9.6d to cover · Moderate squeeze

1.3%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

14.4% of float

123.9M sh

Public Float

65/100

Dilution Score

High

3 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

65/100

HIGH

Inst: 1.26% · Top: Blackrock Inc.

Biotech Analytics

Cardiovascular

62.52

Dilution Risk: HIGHSqueeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk65

Clinical Trials100

Short Interest50